Bhat G, Shastry A
Indian J Pharmacol. 2024; 56(4):242-247.
PMID: 39250620
PMC: 11483042.
DOI: 10.4103/ijp.ijp_310_23.
Motawi A, GamalEl Din S, Meatmed E, Fahmy I
Int Urol Nephrol. 2024; 56(8):2531-2537.
PMID: 38433177
PMC: 11266281.
DOI: 10.1007/s11255-024-04003-x.
Villapalos-Garcia G, Zubiaur P, Marian-Revilla C, Soria-Chacartegui P, Navares-Gomez M, Mejia-Abril G
J Pers Med. 2023; 13(11).
PMID: 38003881
PMC: 10672114.
DOI: 10.3390/jpm13111566.
Kilic M, Caglayan V, Sambel M, Erdogan A, Onen E, Kurtoglu U
Sex Med. 2023; 11(3):qfad042.
PMID: 37529683
PMC: 10388700.
DOI: 10.1093/sexmed/qfad042.
Wang H, Liu X, Zhang Z, Han Z, Jiang Y, Qiao Y
Sex Med. 2023; 11(2):qfad019.
PMID: 37256219
PMC: 10225468.
DOI: 10.1093/sexmed/qfad019.
Recent Progress in Heterocycle Synthesis: Cyclization Reaction with Pyridinium and Quinolinium 1,4-Zwitterions.
Wang Z, You Y, Zhao J, Zhang Y, Yin J, Yuan W
Molecules. 2023; 28(7).
PMID: 37049822
PMC: 10095670.
DOI: 10.3390/molecules28073059.
Efficacy and safety of low-intensity extracorporeal shock wave therapy versus on-demand tadalafil for erectile dysfunction.
Zanaty F, Badawy A, Kotb H, Elsarfy F, Salman B
Arab J Urol. 2022; 20(4):189-194.
PMID: 36353469
PMC: 9639488.
DOI: 10.1080/2090598X.2022.2090134.
Selecting an Individualized Treatment Approach: The Predictive Value of Erotic Stimulation and Nocturnal Erections for Efficacy of Tadalafil and Cure in Patients With Erectile Dysfunction.
Liu Z, Wu T, Ma S, Xue W, Jiang X, Tang Q
Front Endocrinol (Lausanne). 2022; 13:915025.
PMID: 35846318
PMC: 9276996.
DOI: 10.3389/fendo.2022.915025.
Discovery of Highly Potent Serotonin 5-HT Receptor Agonists Inspired by Heteroyohimbine Natural Products.
Orr M, Cao A, Wang C, Gaisin A, Csakai A, Friswold A
ACS Med Chem Lett. 2022; 13(4):648-657.
PMID: 35450369
PMC: 9014500.
DOI: 10.1021/acsmedchemlett.1c00694.
Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold.
Bojarska J, Mieczkowski A, Ziora Z, Skwarczynski M, Toth I, Shalash A
Biomolecules. 2021; 11(10).
PMID: 34680148
PMC: 8533947.
DOI: 10.3390/biom11101515.
Diketopiperazine-Based, Flexible Tadalafil Analogues: Synthesis, Crystal Structures and Biological Activity Profile.
Mieczkowski A, Speina E, Trzybinski D, Winiewska-Szajewska M, Winska P, Borsuk E
Molecules. 2021; 26(4).
PMID: 33546456
PMC: 7913621.
DOI: 10.3390/molecules26040794.
Erectile Dysfunction: A Primer for in Office Management.
Sami S, Stern N, Di Pierdomenico A, Katz B, Brock G
Med Sci (Basel). 2019; 7(9).
PMID: 31470566
PMC: 6780163.
DOI: 10.3390/medsci7090090.
Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study.
Ozkidik M, Gokce M, Yaman O
Turk J Urol. 2018; 44(4):294-297.
PMID: 29799405
PMC: 6016656.
DOI: 10.5152/tud.2018.46666.
Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia.
Olesovsky C, Kapoor A
Ther Adv Urol. 2016; 8(4):257-271.
PMID: 27928428
PMC: 5131741.
DOI: 10.1177/1756287216650132.
Erectile dysfunction.
Yafi F, Jenkins L, Albersen M, Corona G, Isidori A, Goldfarb S
Nat Rev Dis Primers. 2016; 2:16003.
PMID: 27188339
PMC: 5027992.
DOI: 10.1038/nrdp.2016.3.
PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.
Noel S, Dhooghe B, Leal T
Front Pharmacol. 2012; 3:167.
PMID: 23024633
PMC: 3444771.
DOI: 10.3389/fphar.2012.00167.
Tadalafil: in the treatment of signs and symptoms of benign prostatic hyperplasia with or without erectile dysfunction.
Curran M
Drugs Aging. 2012; 29(9):771-81.
PMID: 23018613
DOI: 10.1007/s40266-012-0010-7.
Tadalafil: in pulmonary arterial hypertension.
Croxtall J, Lyseng-Williamson K
Drugs. 2010; 70(4):479-88.
PMID: 20205489
DOI: 10.2165/11204580-000000000-00000.
Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics.
Forgue S, Phillips D, Bedding A, Payne C, Jewell H, Patterson B
Br J Clin Pharmacol. 2006; 63(1):24-35.
PMID: 16869816
PMC: 2000708.
DOI: 10.1111/j.1365-2125.2006.02726.x.
Tadalafil pharmacokinetics in healthy subjects.
Forgue S, Patterson B, Bedding A, Payne C, Phillips D, Wrishko R
Br J Clin Pharmacol. 2006; 61(3):280-8.
PMID: 16487221
PMC: 1885023.
DOI: 10.1111/j.1365-2125.2005.02553.x.